Peptides as epigenetic modulators: therapeutic implications

被引:0
|
作者
Yorick Janssens
Evelien Wynendaele
Wim Vanden Berghe
Bart De Spiegeleer
机构
[1] Ghent University,Drug Quality and Registration (DruQuaR) group, Faculty of Pharmaceutical Sciences
[2] University of Antwerp,Protein Science, Proteomics and Epigenetic Signaling (PPES), Department Biomedical Sciences
来源
Clinical Epigenetics | 2019年 / 11卷
关键词
Peptides; Epigenetics; Therapeutical development; Drug repositioning;
D O I
暂无
中图分类号
学科分类号
摘要
Peptides originating from different sources (endogenous, food derived, environmental, and synthetic) are able to influence different aspects of epigenetic regulation. Endogenous short peptides, resulting from proteolytic cleavage of proteins or upon translation of non-annotated out of frame transcripts, can block DNA methylation and hereby regulate gene expression. Peptides entering the body by digestion of food-related proteins can modulate DNA methylation and/or histone acetylation while environmental peptides, synthesized by bacteria, fungi, and marine sponges, mainly inhibit histone deacetylation. In addition, synthetic peptides that reverse or inhibit different epigenetic modifications of both histones and the DNA can be developed as well. Next to these DNA and histone modifications, peptides can also influence the expression of non-coding RNAs such as lncRNAs and the maturation of miRNAs.
引用
收藏
相关论文
共 50 条
  • [1] Peptides as epigenetic modulators: therapeutic implications
    Janssens, Yorick
    Wynendaele, Evelien
    Vanden Berghe, Wim
    De Spiegeleer, Bart
    [J]. CLINICAL EPIGENETICS, 2019, 11 (1)
  • [2] Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer
    Walsh, Louise
    Gallagher, William M.
    O'Connor, Darran P.
    Chonghaile, Triona Ni
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (05) : 541 - 551
  • [3] Epigenetic Modulators as Therapeutic Agents in Cancer
    Patnaik, Eshaan
    Madu, Chikezie
    Lu, Yi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [4] Epigenetic modulators as therapeutic targets in prostate cancer
    Inês Graça
    Eva Pereira-Silva
    Rui Henrique
    Graham Packham
    Simon J. Crabb
    Carmen Jerónimo
    [J]. Clinical Epigenetics, 2016, 8
  • [5] Epigenetic modulators as therapeutic targets in prostate cancer
    Graca, Ines
    Pereira-Silva, Eva
    Henrique, Rui
    Packham, Graham
    Crabb, Simon J.
    Jeronimo, Carmen
    [J]. CLINICAL EPIGENETICS, 2016, 8
  • [6] Short Biologically Active Peptides as Epigenetic Modulators of Gene Activity
    Vanyushin, B. F.
    Khavinson, V. Kh.
    [J]. EPIGENETICS - A DIFFERENT WAY OF LOOKING AT GENETICS, 2016, : 69 - 90
  • [7] Small molecule modulators of epigenetic modifications: Implications in therapeutics
    [J]. Kundu, T.K. (tapas@jncasr.ac.in), 1600, Indian Academy of Sciences (102):
  • [8] Small molecule modulators of epigenetic modifications: implications in therapeutics
    Selvi, B. Ruthrotha
    Senapati, Parijat
    Kundu, Tapas K.
    [J]. CURRENT SCIENCE, 2012, 102 (01): : 29 - 36
  • [9] Epigenetic aberrations and therapeutic implications in gliomas
    Natsume, Atsushi
    Kondo, Yutaka
    Ito, Motokazu
    Motomura, Kazuya
    Wakabayashi, Toshihiko
    Yoshida, Jun
    [J]. CANCER SCIENCE, 2010, 101 (06) : 1331 - 1336
  • [10] Insights into the Therapeutic Potential of Phytoconstituents as an Epigenetic Modulators in Diabetic Nephropathy
    Thapa, Komal
    Khan, Heena
    Grewal, Amarjot Kaur
    Kanojia, Neha
    Kaur, Gagandeep
    Sood, Parul
    Singh, Thakur Gurjeet
    [J]. CURRENT PHARMACOLOGY REPORTS, 2023, 9 (06) : 404 - 426